Dr. Chi Pham, MD
What this data tells you about Dr. Pham
Dr. Chi Pham is a hematology & oncology specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pham performed 51,566 Medicare services across 2,765 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pham received a total of $7,015 from 33 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pham is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) | 11,400 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 11,100 | $43 | $137 |
| Paclitaxel chemotherapy injection | 8,262 | $0 | $8 |
| Azacitidine chemotherapy injection | 5,200 | $0 | $13 |
| Iron sucrose injection (Venofer) | 4,200 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $66 |
| Dexamethasone injection (steroid) | 1,529 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 900 | $1 | $114 |
| Blood draw (venipuncture) | 797 | $8 | $20 |
| Complete blood count (CBC) with differential | 747 | $8 | $36 |
| Comprehensive metabolic blood panel | 686 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 620 | $0 | $24 |
| Injection, leucovorin calcium, per 50 mg | 454 | $3 | $25 |
| Office visit, established patient (30-39 min) | 438 | $92 | $368 |
| Injection, fluorouracil, 500 mg | 357 | $2 | $13 |
| Injection of additional new drug or substance into vein | 291 | $12 | $108 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 246 | $20 | $128 |
| Injection, carboplatin, 50 mg | 230 | $2 | $300 |
| Administration of chemotherapy into vein, 1 hour or less | 225 | $101 | $707 |
| Office visit, established patient (20-29 min) | 156 | $54 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 148 | $22 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 113 | $16 | $100 |
| Injection, diphenhydramine hcl, up to 50 mg | 97 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 91 | $49 | $313 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 89 | $57 | $211 |
| Injection, zoledronic acid, 1 mg | 85 | $6 | $431 |
| Administration of additional new drug or substance into vein, 1 hour or less | 77 | $50 | $344 |
| Drug injection, under skin or into muscle | 76 | $11 | $96 |
| Administration of chemotherapy into vein, each additional hour | 70 | $22 | $161 |
| Iron level test | 67 | $6 | $27 |
| Iron binding capacity test | 67 | $9 | $35 |
| Ferritin level test (iron stores) | 66 | $13 | $60 |
| Infusion into a vein for hydration, each additional hour | 52 | $10 | $75 |
| Unclassified drugs | 51 | $1 | $9 |
| Microscopic examination for white blood cells with manual cell count | 50 | $4 | $22 |
| Complete blood count (CBC), automated | 50 | $6 | $34 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 46 | $133 | $500 |
| Lactate dehydrogenase (enzyme) level | 45 | $6 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 38 | $16 | $94 |
| Administration of additional new drug or substance into vein using push technique | 38 | $43 | $289 |
| Hospital follow-up visit, high complexity | 32 | $92 | $357 |
| Office visit, established patient, complex (40-54 min) | 30 | $136 | $496 |
| Infusion, normal saline solution , 1000 cc | 28 | $2 | $19 |
| Vitamin B-12 level test | 27 | $15 | $76 |
| Immunoglobulin level test | 24 | $9 | $56 |
| Measurement of immunoglobulin light chains | 24 | $17 | $60 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $90 | $657 |
| Irrigation of implanted venous access drug delivery device | 19 | $17 | $114 |
| Echocardiogram, transthoracic | 18 | $137 | $843 |
| New patient office visit, complex (60-74 min) | 18 | $162 | $709 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 16 | $25 | $145 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 14 | $1,163 | $4,802 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (52%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pham is a mixed practice specialist, with above-average Medicare volume (top 19% in TX), with consulting-driven industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pham experienced with anti-nausea injection (fosaprepitant)?
Does Dr. Pham receive payments from pharmaceutical companies?
How do Dr. Pham's costs compare to other hematology & oncology specialists in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology